BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAMED - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAMED
X-ORIGINAL-URL:https://samed.org.za
X-WR-CALDESC:Events for SAMED
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20260305T100000
DTEND;TZID=Africa/Johannesburg:20260305T123000
DTSTAMP:20260516T065915
CREATED:20260116T135440Z
LAST-MODIFIED:20260205T093844Z
UID:16273-1772704800-1772713800@samed.org.za
SUMMARY:Market Access Forum
DESCRIPTION:This forum unpacks Council for Medical Schemes latest report and relevance to the MedTech sector\, Life Healthcare’s procurement processes and strategy\, and Medscheme’s HTA direction. \nProgramme \n10:00 – 10:30 \nBehind the Numbers: Key Insights & Trends from the Latest CMS Industry Report \nSpeaker: Carrie-Anne Cairncross\, Senior Researcher\, Council for Medical Schemes \nDelegates will gain: \n\nClear interpretation of key CMS data trends impacting funding\, utilisation\, and affordability\nInsight into policy and regulatory signals shaping scheme behaviour and reimbursement decisions\nPractical understanding of what the data means for medtech positioning\n\n10:30 – 11:15 \nDemystifying Life Healthcare’s Procurement Process \nSpeaker: Passmore Musungwa\, Category Manager\, Life Healthcare \nDelegates will gain: \n\nTransparency into how procurement decisions are made within a major private hospital group\nPractical guidance on supplier expectations and evaluation criteria\nImproved readiness to engage private hospital procurement strategically\n\n11:15 – 11:45 \nMedscheme Health Policy Unit: Medtech HTA Update \nSpeaker: Christeen Keyter\, Advanced Specialist: Health Policy Development Technology\, Medscheme \nDelegates will gain: \n\nInsight into recent HTA developments and policy priorities\nClarity on evidence requirements for medtech reimbursement\nContext for stronger engagement with medical schemes\n\n11:45 – 12:15 \nPre-launch HTA Webinar Series \nSpeaker: Dr Tienie Stander\, Managing Director\, Value in Research \nDelegates will gain: \n\nA deeper understanding of how HTA for medical devices differs from pharmaceuticals\nPractical guidance to prepare and plan HTA submissions for Medical Scheme Administrators\n\nWho Should Attend \n\nPersonnel engaging medical schemes and procurers (public and private sector)\nMarket Access Specialists\nReimbursement Specialists\n\nCost to Attend \n\nSAMED Members: Free\nNon-Members (medtech companies and service providers to the medtech industry only): R500.00 per person (excl. VAT)\nContact Nomthi Mnisi at communication@samed.org.za to request an invoice prior to registering.\n\nT&Cs \n\nSAMED reserves the right to approve / prohibit registration by non-members\nAttendance will only be permitted if fee paid in advance of the event.\n\nRegistration \nClick here to register
URL:https://samed.org.za/event/market-access-forum-5/
ATTACH;FMTTYPE=image/png:https://samed.org.za/wp-content/uploads/2026/01/MA-for-website-5-scaled.png
END:VEVENT
END:VCALENDAR